Navigation Links
China Cord Blood Corporation Warrant Registration Statement Declared Effective by SEC
Date:2/11/2010

HONG KONG, Feb. 11 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation ("CCBC" or "the Company") (NYSE: CO), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Securities and Exchange Commission ("SEC") declared the Company's registration statement effective on February 9, 2010. The registration statement relates to the ordinary shares underlying warrants and certain other securities issued in connection with the initial public offering of Pantheon China Acquisition Corp.

As a result of the effectiveness, holders of public warrants issued and outstanding may now exercise them and receive ordinary shares upon the payment of the related exercise price.

If you have any questions regarding exercise procedures, please call your broker or Continental Stock Transfer & Trust at 212.509.4000 ext. 541.

About China Cord Blood Corporation

China Cord Blood Corporation is the first and the largest cord blood banking operator in China in terms of geographical coverage and is the only cord blood bank operator with more than one license (i.e., Beijing and Guangdong). Under the current PRC government regulations, only one licensed cord blood bank operator is permitted to operate in each licensed region and only six licenses have been issued as of today. China Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services. For more information about China Cord Blood Corporation, please visit: http://www.chinacordbloodcorp.com .

    For more information, please contact:

    China Cord Blood Corporation

     Ms. Joeling Law
     Phone: +852-3605-8180
     Email: ir@chinacordbloodcorp.com

    ICR, Inc.

     In the United States:
     Ashley M. Ammon or Christine Duan
     Phone: +1-646-277-1200

     In China:
     Wei-Jung Yang
     Phone: +86-10-6599-7968

SOURCE China Cord Blood Corporation


'/>"/>
SOURCE China Cord Blood Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. MIT China joint venture is preparing a major commercial launch in July 2010
2. Major milestone achieved by our joint venture in China
3. Jion Beijing Great Wall International Travel Agency Immediate Exposure to China Expo 2010
4. China Sky One Medical, Inc. Featured by Science and Technology Daily
5. Significant urban-rural disparities in injury mortality seen in China
6. China a rising star in regenerative medicine despite world skepticism of stem cell therapies
7. China Nepstar Chain Drugstore Announces Change to the Board
8. China rapidly catching up in research impact
9. CordLife Secures Strategic Presence in China
10. China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009
11. China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... Bioclinica® ... sponsors and CROs to speed clinical development, has released the industry’s only ... Bioclinica AGILE RTSM provides seamless clinical supply forecasting and management together ...
(Date:4/25/2017)... KY (PRWEB) , ... April 25, 2017 , ... ... announce they have signed an agreement to be the preferred physical therapy provider ... injuries and returning them to Derby City CrossFit as quickly and effectively as ...
(Date:4/25/2017)... ... April 25, 2017 , ... A recent report from the ... for the 2015-16 school year across Wisconsin’s public schools, charter schools, and private ... patterns in student test score performance, the report’s limited analyses fail to provide ...
(Date:4/25/2017)... ... 2017 , ... As pharmaceutical companies are held to increasingly ... innovation in drug formulation and manufacturing. CoreRx offers its clients more than ... support of their development and manufacturing goals. , The company was created ...
(Date:4/25/2017)... Scotch Plains, NJ (PRWEB) , ... April 25, 2017 , ... Saad B. Chaudhary, MD ... with the treatment of acute or chronic problems, I focus on preventative care with all ... patient. If you have any questions, always feel free to contact my office and my ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... April 19, 2017 Global Surgical Drainage Device ... tubes used to remove excess liquid and air. The ... urine, bile or lymph. Surgical drains are used in ... as orthopedics surgery, cardiovascular surgery, neurosurgery, plastic surgery etc. ... to prevent accumulation of fluid e.g. blood or pus. ...
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group ... it is developing at Conejo Spectrum Business Park ... to Atara Biotherapeutics, Inc. , a biopharmaceutical ... and life-threatening diseases that have been underserved by ... T-cell therapies for cancer, autoimmune and infectious disease. ...
Breaking Medicine Technology: